SA’s medicines regulator has granted a Section 21 authorisation for the Pfizer/BioNTech Covid-19 vaccine, clearing the way for the shot to be imported and administered before it has been registered in SA.

Section 21 of the Medicines and Related Substances Act allows the SA Health Products Regulatory Authority (Sahpra) to grant permission for the administration of unregistered medicines, provided they have been approved by a stringent regulator such as the US Food and Drug Administration or the European Medicines Authority. It has yet to finalise Pfizer’s application to register its Covid-19 vaccine, branded Comirnaty...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now